FrancophonIA/ELRC3.0 huggingface dataset:
English: Voriconazole Accord is also used to prevent fungal infections in patients who have had haematopoietic (blood) stem-cell transplantation (a transplant of a type of stem cells that can develop into blood cells) and are at high risk of infection.
Croatian: Voriconazole Accord se također primjenjuje za prevenciju gljivičnih infekcija u primatelja hematopoetske transplantacije (krvnih) matičnih stanica (transplantacije vrste matičnih stanica koje se mogu razviti u krvne stanice) s visokim rizikom od infekcije.
English: This is a summary of the European public assessment report (EPAR) for Voriconazole Accord.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Voriconazole Accord.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Voriconazole Accord on 16 May 2013.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za lijek Voriconazole Accord na snazi u Europskoj uniji od 16. svibnja 2013.
English: When used for treating fungal infections, Voriconazole Accord is intended mainly for patients with worsening, possibly life-threatening, fungal infections.
Croatian: Kada se primjenjuje za liječenje gljivičnih infekcija, Voriconazole Accord je uglavnom namijenjen bolesnicima s gljivičnim infekcijama koje se pogoršavaju, a mogu biti opasne po život.
English: Voriconazole Accord is a ‘generic medicine'.
Croatian: Voriconazole Accord je „generički lijek”.
English: Voriconazole Accord voriconazole
Croatian: Voriconazole Accord vorikonazol
English: Because Voriconazole Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Croatian: Budući da je lijek Voriconazole Accord generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i kod referentnog lijeka.
English: The Committee recommended that Voriconazole Accord be approved for use in the EU.
Croatian: Odbor je preporučio izdavanje odobrenja za primjenu lijeka Voriconazole Accord u EU-u.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Voriconazole Accord, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana u sažetak opisa svojstava lijeka i uputu o lijeku za Voriconazole Accord nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: What measures are being taken to ensure the safe and effective use of Voriconazole Accord?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Voriconazole Accord?
English: The dose of Voriconazole Accord depends on the weight of the patient.
Croatian: Doza lijeka Voriconazole Accord ovisi o tjelesnoj težini bolesnika.
English: A risk management plan has been developed to ensure that Voriconazole Accord is used as safely as possible.
Croatian: Pripremljen je plan upravljanja rizikom kako bi se osigurala što sigurnija primjena lijeka Voriconazole Accord.
English: • serious invasive Candida infections when the fungus is resistant to fluconazole (another antifungal medicine);
Croatian: • teškim invazivnim infekcijama uzrokovanima gljivicom Candida u slučaju kada je gljivica rezistentna na flukonazol (drugi antifungalni lijek);
English: It is not intended to provide practical advice on how to use Voriconazole Accord.
Croatian: Svrha sažetka nije davati praktične savjete o korištenju lijeka Voriconazole Accord.
English: For more information about treatment with Voriconazole Accord, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Voriconazole Accord pročitajte u uputi o lijeku (također dio EPAR-a), ili se obratite svom liječniku ili ljekarniku.
English: What is Voriconazole Accord and what is it used for?
Croatian: Što je Voriconazole Accord i za što se koristi?
English: Therefore, the CHMP's view was that, as for Vfend, the benefit outweighs the identified risks.
Croatian: Stoga je stav CHMP-a da koristi nadmašuju utvrđene rizike, kao i kod lijeka Vfend.
English: Because Voriconazole Accord is a generic medicine, studies in patients have been limited to tests to determine that it is bioequivalent to the reference medicine, Vfend.
Croatian: Budući da je lijek Voriconazole Accord generički lijek, ispitivanja na bolesnicima bila su ograničena na ispitivanja za utvrđivanje bioekvivalentnosti s referentnim lijekom Vfend.
English: Other information about Voriconazole Accord
Croatian: Ostale informacije o lijeku Voriconazole Accord
English: The list of fungi against which Voriconazole Accord is active can be found in the summary of product characteristics (also part of the EPAR).
Croatian: Popis gljivica protiv kojih je Voriconazole Accord aktivan dostupan je u sažetku opisa svojstava lijeka (također dio EPAR-a).
English: Voriconazole Accord is an antifungal medicine that contains the active substance voriconazole.
Croatian: Voriconazole Accord je antifungalni lijek koji sadrži djelatnu tvar vorikonazol.
English: What are the benefits and risks of Voriconazole Accord?
Croatian: Koje su koristi i rizici lijeka Voriconazole Accord?
English: The active substance in Voriconazole Accord, voriconazole, is an antifungal medicine that belongs to the ‘triazole' group.
Croatian: Djelatna tvar u lijeku Voriconazole Accord, vorikonazol, antifungalni je lijek koji se ubraja u skupinu „triazola”.
English: For practical information about using Voriconazole Accord, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o korištenju lijeka Voriconazole Accord pročitajte u uputi o lijeku, odnosno obratite se svom liječniku ili ljekarniku.
English: For full information, see the package leaflet.
Croatian: Za dodatne informacije vidjeti uputu o lijeku.
English: Why is Voriconazole Accord approved?
Croatian: Zašto je Voriconazole Accord odobren?
English: • candidaemia (another type of fungal infection due to Candida) in non-neutropenic patients
Croatian: • kandidemijom (vrstom gljivične infekcije uzrokovane gljivicom Candida) u bolesnika koji nemaju neutropeniju (bolesnika s normalnim brojem bijelih krvnih stanica);
English: How does Voriconazole Accord work?
Croatian: Kako djeluje Voriconazole Accord?
English: How is Voriconazole Accord used?
Croatian: Kako se Voriconazole Accord koristi?
English: How has Voriconazole Accord been studied?
Croatian: Kako je Voriconazole Accord ispitivan?
English: The entire content of the bottle should be used immediately after broaching and during the same procedure.
Croatian: Cijeli sadržaj bočice treba upotrijebiti neposredno nakon otvaranja i tijekom istog postupka.
English: These clinical signs have been reported very rarely from the field.
Croatian: Ovaj klinički znak rijetko je prijavljen s terena.
English: Date of last renewal: 07/11/2014
Croatian: Datum zadnjeg produljenja odobrenja: 07/11/2014
English: ATC vet code: QI04AA02
Croatian: ATCvet kôd: QI04AA02.
English: Girona SPAIN
Croatian: Girona ŠPANJOLSKA
English: The duration of immunity is at least 1 year after the primary vaccination course.
Croatian: Imunitet traje barem 1 godinu nakon primarnog ciklusa cijepljenja.
English: Shelf-life of the veterinary medicinal product as packaged for sale: 1 year.
Croatian: Rok valjanosti veterinarsko-medicinskog proizvoda kada je zapakiran za prodaju: 1 godina.
English: EU/2/09/104/001 EU/2/09/104/002
Croatian: EU/2/09/104/002
English: Onset of immunity: 25 days after administration of the second dose.
Croatian: Početak imuniteta: 25 dana nakon primjene druge doze.
English: The level of efficacy for other species may differ from that observed in sheep.
Croatian: Djelotvornost u drugih vrsta može se razlikovati od one uočene u ovaca.
English: Avoid bubble formation, as this can be irritating at the site of injection.
Croatian: Izbjegavajte stvaranje mjehurića jer oni mogu iritirati mjesto ubrizgavanja.
English: 6.5 Nature and composition of immediate packaging Type II glass bottle with butyl elastomer closure.
Croatian: 6.5 Osobine i sastav unutarnjeg pakovanja Staklena bočica tipa II sa zatvaračem od butil elastomera.
English: - very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals) - uncommon (more than 1 but less than 10 animals in 1,000 animals) - rare (more than 1 but less than 10 animals in 10,000 animals) - very rare (less than 1 animal in 10,000 animals, including isolated reports)
Croatian: Učestalost nuspojava je određena sukladno sljedećim pravilima: - vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana) - česte (više od 1 ali manje od 10 životinja na 100 životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 životinja) - rijetke (više od 1 ali manje od 10 životinja na 10.000 životinja) - vrlo rijetke (manje od 1 životinje na 10.000 životinja, uključujući izolirane slučajeve).
English: Potassium dihydrogen phosphate Disodium hydrogen phosphate dodecahydrate Sodium chloride
Croatian: Kalijev dihidrogenfosfat Dinatrijev hidrogenfosfat dodekahidrat Natrijev klorid
English: Do not use this veterinary medicinal product after the expiry date which is stated on the carton and on the label after EXP.
Croatian: Ne koristite veterinarsko-medicinski proizvod poslije isteka roka valjanosti naznačenog na etiketi poslije EXP.
English: The use of this veterinary medicinal product is only allowed under the particular conditions established by European Community legislation on the control of bluetongue.
Croatian: Primjena ovog veterinarsko-medicinskog proizvoda dopuštena je samo pod određenim uvjetima koje utvrđuju propisi Europske unije o kontroli bolesti plavog jezika.
English: United Kingdom Zoetis UK Limited
Croatian: Zoetis UK Limited
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 15/01/2010
Croatian: Datum prvog odobrenja: 15/01/2010
English: Avoid multiple vial broaching.
Croatian: Izbjegavajte višestruko otvaranje bočice.
English: Portugal Zoetis Portugal, Lda.
Croatian: Zoetis Portugal, Lda.
English: Österreich Zoetis Österreich GmbH
Croatian: Zoetis Österreich GmbH
English: D. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION The periodic safety update report (PSUR) cycle should be restarted for submission of 6 monthly reports (covering all authorised presentations of the product) for the next two years, followed by yearly reports for the subsequent two years and thereafter at 3 yearly intervals, unless otherwise required.
Croatian: Periodička izvješća o neškodljivosti (PSUR) treba ponovo podnositi putem 6 mjesečnih izvješća (pokrivajući sva odobrena pakovanja proizvoda) za naredne dvije godine, nakon kojih slijede godišnja izvješća za sljedeće dvije godine, a nakon toga u trogodišnjim intervalima, ako nije drugačije zatraženo.
English: Shelf-life after first opening the immediate packaging: use immediately.
Croatian: Rok valjanosti poslije prvog otvaranja unutarnjeg pakovanja: upotrijebiti odmah.
English: Pharmacotherapeutic group: Inactivated viral vaccines - bluetongue virus vaccine.
Croatian: Farmakoterapijska skupina: inaktivirana virusna cjepiva - cjepivo protiv virusa bolesti plavog jezika.
English: The active substance being a principle of biological origin intended to produce active immunity is not within the scope of Regulation (EC) No 470/2009.
Croatian: Djelatna tvar koja se sastoje od tvari biološkog podrijetla, namijenjena je za stvaranje aktivne imunosti i na koje se ne primjenjuju odredbe Uredbe (EZ) br. 470/2009.
English: As the duration of immunity is not yet fully established, any revaccination scheme should be agreed by the Competent Authority or by the responsible veterinarian, taking into account the local epidemiological situation.
Croatian: Budući da trajanje imuniteta još nije u potpunosti ustanovljeno, shemu revakcinacije treba utvrditi nadležno tijelo ili odgovorni veterinar uzimajući u obzir lokalnu epidemiološku situaciju.
English: In this category of animals the vaccine should be used only according to the benefit/risk assessment by the responsible veterinarian and/or national Competent Authorities on the current vaccination policies against BTV.
Croatian: U ovoj kategoriji životinja cjepivo bi trebalo primjenjivati samo u skladu s procjenom odgovornog veterinara o odnosu koristi i rizika i/ili u skladu s odlukama nacionalnog nadležnog tijela o trenutačnoj politici cijepljenja protiv virusa bolesti plavog jezika.
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
Croatian: IME I ADRESA NOSITELJA ODOBRENJA ZA STAVLJANJE U PROMET I NOSITELJA ODOBRENJA ZA PROIZVODNJU ODGOVORNOG ZA PUŠTANJE SERIJE U PROMET, AKO JE RAZLIČITO
English: SPECIAL WARNING(S), IF NECESSARY Read the package leaflet before use.
Croatian: POSEBNA UPOZORENJA, UKOLIKO JE POTREBNO Prije upotrebe pročitati uputu o VMP.
English: Aluminium hydroxide (Al3+)
Croatian: Adjuvansi: Aluminij-hidroksid (Al3+)
English: Any person intending to manufacture, import, possess, sell, supply and use ZULVAC 8 Ovis must consult the relevant Member State's competent authority on the current vaccination policies prior to the manufacture, import, possession, sale, supply and/or use.
Croatian: Tko namjerava proizvoditi, uvesti, posjedovati, prodavati, opskrbljivati i/ili primjenjivati ZULVAC 8 Ovis mora se savjetovati s nadležnim tijelom odnosne države članice u pogledu važećih odredbi o cijepljenju prije proizvodnje, uvoza, posjedovanja, prodaje, opskrbe i/ili primjene.
English: Do not mix with any other veterinary medicinal product.
Croatian: Ne miješajte s drugim veterinarsko-medicinskim proizvodom.
English: PHARMACEUTICAL FORM Off-white or pink suspension for injection
Croatian: OBLIK Bjelkasta do ružičasta suspenzija za injekciju.
English: Pack of 1 bottle of 50 doses (100 ml).
Croatian: Pakovanje od 1 bočice s 50 doza (100 ml).
English: No information is available on the use of the vaccine in seropositive animals including those with maternally derived antibodies.
Croatian: Nisu dostupne informacije o primjeni cjepiva na seropozitivnim životinjama, uključujući one kod kojih su antitijela prenesena s majke .
English: 100 ml (50 doses) 240 ml (120 doses)
Croatian: VELIČINA PAKOVANJA 100 ml (50 doza) 240 ml (120 doza)
English: To stimulate active immunity against bluetongue virus, serotype 8 in sheep.
Croatian: Za stimulaciju aktivnog imuniteta na virus bolesti plavog jezika serotipa 8 u ovaca.
English: According to Article 71 of Directive 2001/82/EC of the European Parliament and of the Council as amended,
Croatian: Sukladno članku 71. Direktive 2001/82/EZ i Europskog Parlamenta i Vijeća s izmjenama i dopunama, države članice, u skladu s nacionalnim zakonodavstvom mogu zabraniti proizvodnju, uvoz,
English: EXPIRY DATE EXP {month/year} Once broached use immediately.
Croatian: EXP {mjesec/godina} Jednom otvoren, odmah upotrijebiti.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION One dose of 2 ml of vaccine contains:
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Jedna doza od 2 ml cjepiva sadrži:
English: Use in other domestic and wild ruminant species that are considered at risk of infection should be undertaken with care and it is advisable to test the vaccine on a small number of animals prior to mass vaccination.
Croatian: Primjenu na ostalim domaćim ili divljim vrstama preživača za koje se smatra da su izloženi infekciji treba poduzeti s posebnim oprezom te se preporučuje testiranje cjepiva na manjem broju životinja prije masovnog cijepljenja.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton box 1 x 100ml / Carton box 1 x 240 ml
Croatian: Kartonska kutija 1 x 100 ml / Kartonska kutija 1 x 240 ml
English: España Zoetis Spain, S.L.
Croatian: Zoetis Spain, S.L.
English: Luxembourg/Luxemburg Zoetis Belgium SA
Croatian: Luxembourg/Luxemburg
English: Pack of 1 bottle of 120 doses (240 ml).
Croatian: Pakovanje od 1 bočice s 120 doza (240 ml).
English: România Zoetis România S.R.L
Croatian: Zoetis România S.R.L
English: Inactivated bluetongue virus, serotype 8, strain BTV-8/BEL2006/02
Croatian: Inaktivirani virus bolesti plavog jezika, serotip 8, soj BTV-8/BEL2006/02
English: Lietuva Oriola Vilnius UAB
Croatian: Oriola Vilnius UAB
English: The import, possession, sale, supply and/or use of this veterinary medicinal product may be prohibited in Member States on the Whole or part of its territory.
Croatian: Uvoz, posjedovanje, prodaja i nabava i/ili primjena ovog veterinarsko medicinskog proizvoda može biti zabranjena u zemljama članicama na cijelom ili dijelu svog teritorija.
English: SPECIAL STORAGE CONDITIONS Store and transport refrigerated .
Croatian: 11. POSEBNI UVIJETI ČUVANJA Čuvati i prevoziti rashlađeno.
English: Aluminium hydroxide
Croatian: Aluminijev-hidroksid Saponin
English: The manufacture, import, possession, sale, supply and/or use of ZULVAC 8 Ovis may be prohibited in a Member State on the whole or part of its territory pursuant to national legislation.
Croatian: Proizvodnja, uvoz, posjedovanje, prodaja, opskrba i/ili primjena ZULVAC 8 Ovis može biti zabranjena u određenim državama članicama na cijelom ili na dijelu njihovog teritorija sukladno nacionalnim propisima.
English: PHARMACEUTICAL FORM Suspension for injection
Croatian: Suspenzija za injekciju.
English: In order to avoid accidental contamination of the vaccine during use, it is recommended to use a multiinjection type vaccination system when larger dose presentations are used.
Croatian: Radi izbjegavanja slučajne kontaminacije cjepiva tijekom primjene većih pakovanja, preporučuje se primjena sustava cijepljenja s višestrukim ubrizgavanjem.
English: PACKAGE LEAFLET FOR: ZULVAC 8 Ovis suspension for injection for sheep
Croatian: UPUTA O VMP ZA: ZULVAC 8 Ovis suspenzija za injekcije za ovce
English: 1st injection: from 1.5 months of age.
Croatian: Primijenite jednu dozu od 2 ml prema sljedećoj shemi cijepljenja: Prva injekcija: od 1,5 mjeseci starosti.
English: These reactions take the form in most cases of a general swelling of the injection site (persisting for not more than 9 days) or of palpable nodules (subcutaneous granuloma possibly persisting for more than 63 days).
Croatian: Takve reakcije u većini slučajeva dolaze u obliku opće otekline (koja ne traje duže od 9 dana) ili opipljivih kvržica (potkožni granulom može trajati više od 63 dana).
English: These reactions take the form in most cases of a general swelling of the injection site (persisting for not more than 9 days) or of palpable nodules (subcutaneous granuloma, possibly persisting for more than 63 days).
Croatian: U većini se slučajeva te reakcije manifestiraju kao otekline na mjestu ubrizgavanja (ne dulje od 9 dana) ili kao opipljivi čvorići (subkutani granulomi, mogu potrajati dulje od 63 dana).
English: a Member State may, in accordance with its national legislation, prohibit the manufacture, import, possession, sale, supply and/or use of immunological veterinary medicinal products on the whole or part of its territory if it is established that:
Croatian: posjedovanje, prodaju, opskrbu i/ili primjenu imunoloških veterinarsko-medicinskih proizvoda na cijelom ili na dijelu svog teritorija ako je utvrđeno da:
English: Incompatibilities Do not mix with any other veterinary medicinal product.
Croatian: Ne miješati s drugim veterinarsko - medicinskim proizvodom.
English: A. MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČI BIOLOŠKI DJELATNIH TVARI I PROIZVOĐAČI ODGOVORNI ZA PUŠTANJE SERIJE U PROMET
English: Special precautions for use in animals Only use in healthy animals.
Croatian: Primjenjivati samo na zdravim životinjama.
English: STATEMENT OF ACTIVE AND OTHER SUBSTANCES One dose of 2 ml contains:
Croatian: KOLIČINA DJELATNE(IH) TVARI Jedna doza od 2 ml sadrži:
English: Active immunisation of sheep from 1.5 months of age for the prevention* of viraemia caused by bluetongue virus, serotype 8.
Croatian: Aktivna imunizacija ovaca od 1,5 mjeseci starosti na dalje, radi prevencije* viremije uzrokovane virusom bolesti plavog jezika serotipa 8. *(Vrijednost cikliranja (Ct) ≥ 36 potvrđenom metodom RT-PCR koja ukazuje da nema viralnog genoma).
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE Vial label 100 ml / Vial label 240 ml
Croatian: Etiketa bočice od 100 ml / Etiketa bočice od 240 ml NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA
English: A transient increase in rectal temperature, not exceeding 0.6 °C, may occur during the 24 hours following administration of a two-fold overdose.
Croatian: Tijekom 24 sata od predoziranja dvostrukom dozom može doći do prolaznog povišenja rektalne temperature koje ne premašuje 0,6 °C.
English: See package leaflet for further information
Croatian: 15. OSTALE INFORMACIJE
English: WITHDRAWAL PERIOD Zero days
Croatian: KARENCIJA Karencija: 0 dana
English: Tlf: +358 (0)9 4300 40
Croatian: Zoetis Finland Oy Tlf: +358 (0)9 4300 40
English: METHOD AND ROUTE(S) OF ADMINISTRATION For subcutaneous use.
Croatian: NAČIN I PUT(EVI) PRIMJENE
English: Sími: +358 (0)9 4300 40
Croatian: Zoetis Finland Oy Sími: +358 (0)9 4300 40
English: Special precautions for use in animals: Only use in healthy animals.
Croatian: Posebne mjere opreza prilikom primjene na životinjama:
English: Puh/Tel: +358 (0)9 4300 40
Croatian: Suomi/Finland Zoetis Finland Oy Puh/Tel: +358 (0)9 4300 40
English: ADVERSE REACTIONS In one laboratory safety study, transient increase in rectal temperature during the 24 hours following vaccination not exceeding 1.2°C and local reaction at the injection site, in most cases in the form of a general swelling (persisting for not more than 7 days) or of palpable nodules (subcutaneous granuloma, possibly persisting for more than 48 days) were observed very commonly.
Croatian: U većini se slučajeva te reakcije manifestiraju kao otekline na mjestu ubrizgavanja (ne dulje od 7 dana) ili kao opipljivi čvorići (supkutani granulomi, mogu potrajati dulje od 48 dana).
English: Tel: +420 257 101 111
Croatian: Česká republika Zoetis Česká republika, s.r.o. Tel: +420 257 101 111
English: The safety and efficacy of Truxima in children below 18 years has not been established.
Croatian: Sigurnost i djelotvornost lijeka Truxima u djece mlađe od 18 godina nisu ustanovljene.
English: When should I not have Truxima?
Croatian: Kada ne smijem primiti lijek Truxima?
English: Date of first authorisation: 17 February 2017 Date of latest renewal:
Croatian: Datum prvog odobrenja: 17. veljače 2017.
English: Your doctor may decide to stop your Truxima treatment if these reactions are serious.
Croatian: Liječnik može odlučiti prekinuti liječenje lijekom Truxima ako su te reakcije ozbiljne.
English: Do not have Truxima if any of the above apply to you.
Croatian: Nemojte primiti lijek Truxima ako se nešto od navedenoga odnosi na Vas.
English: Truxima is indicated in adults for the following indications:
Croatian: Truxima je indicirana u odraslih u sljedećim indikacijama:
English: Truxima may also cause changes in laboratory tests carried out by your doctor.
Croatian: Truxima može uzrokovati i promjene u nalazima laboratorijskih pretraga koje provodi Vaš liječnik.
English: If you can get pregnant, you and your partner must use an effective method of contraception while using Truxima.
Croatian: Ako ste u dobi kada možete zatrudnjeti, Vi i Vaš partner morate koristiti učinkovitu kontracepciju tijekom liječenja lijekom Truxima.
English: Other medicines and Truxima
Croatian: Drugi lijekovi i Truxima
English: Do not have Truxima if you have an active infection or a serious problem with your immune system.
Croatian: Ne smijete primiti lijek Truxima ako imate aktivnu infekciju ili ozbiljne poteškoće s imunološkim sustavom.
English: Contents of the pack and other information What Truxima contains
Croatian: Sadržaj pakiranja i druge informacije Što Truxima sadrži